Laboratoire Atlas
Canada Updated 9 July 2026
Laboratoire Atlas is a finished-dose manufacturer based in Canada. It appears in 24 regulatory filings across 2 regulators, without an active US DMF or CEP on file. Its filings concentrate with Health Canada and ARCSA (EC). Its GMP standing is certified by US FDA. Its most recent recorded inspection, by US FDA, closed on 7 March 2025 as VAI.
1
registered plants
1 with an FDA FEI number
24
filings
across 2 regulators
These figures were checked against the regulators' own files on 25 July 2026
Inspections
4 of 4 confirmed
Sources: FDA Establishment Registration, read 4 May 2026. FDA drug inspection classifications, read 4 May 2026.
Inspection history
- 7 March 2025 VAI US FDA
- 26 April 2019 VAI US FDA
- 11 May 2016 VAI US FDA
- 14 January 2011 VAI US FDA
NAI means no action indicated, VAI means voluntary action indicated, and OAI means
official action indicated.
Registered plants
| Site | FDA FEI |
| Canada, Canada | 3007083710 |
Filings and GMP by regulator
| Regulator | Filings | GMP certificates |
| Health Canada | 23 | None |
| ARCSA (EC) | 1 | None |
| US FDA | None | 1 |
Comparing suppliers?
Choose your molecules and target markets. Laboratoire Atlas comes back tiered against every other
supplier able to file there.
Start for free No sales call.
Open risk flags
- The most recent inspection outcome was VAI, on 7 March 2025.
Sources on this page
- FDA
- Drug master files, establishment registration, inspection classifications
- EDQM
- Certificates of suitability
- EudraGMDP and national regulators
- GMP certificates